Researchers characterize biomechanics of ovarian cells according to phenotype at stages of cancer

Jul 05, 2011

Masoud Agah directs Virginia Tech's Microelectromechanical Systems Laboratory or VT MEMS Lab. The lab resides within the Bradley Department of Electrical and Computer Engineering and is affiliated with the Department of Mechanical Engineering and the MicrON Research Group. Some of its recent work includes: the development of micro gas analyzers for environmental and health-care applications, and biochips for cancer diagnosis and cancer treatment monitoring. Credit: Virginia Tech Photo

Using ovarian surface epithelial cells from mice, researchers from Virginia Tech have released findings from a study that they believe will help in cancer risk assessment, cancer diagnosis, and treatment efficiency in a technical journal: Nanomedicine.

By studying the viscoelastic properties of the ovarian cells of mice, they were able to identify differences between early stages of ovarian cancer and more advanced and aggressive phenotypes.

Their studies showed a mouse's ovarian cells are stiffer and more viscous when they are benign. Increases in cell deformation "directly correlates with the progression from a non-tumor benign cell to a malignant one that can produce tumors and metastases in mice," said Masoud Agah, director of Virginia Tech's Microelectromechanical Systems (MEMS) Laboratory and the lead investigator on the study.

Their findings are consistent with a University of California at Los Angeles study that reported lung, breast, and pancreatic metastatic cells are 70 percent softer than benign cells.

The findings also support Agah group's previousreports on elastic properties of breast cell lines.

Agah worked with Eva Schmelz of Virginia Tech's Department of Human Nutrition, Foods, and Exercise, Chris Roberts of the Virginia-Maryland Regional College of Veterinary Medicine, and Alperen N. Ketene, a graduate student in mechanical engineering, on this work supported by the National Science Foundation and Virginia Tech's Institute for Critical Technology and Applied Science.

They are among a number of researchers attempting to decipher the association of molecular and mechanical events that lead to cancer and its progression. As they are successful, physicians will be able to make better diagnostic and treatment decisions based not only on an individual's genetic fingerprint but also a biomechanical signature.

However, since cancer has multiple causes, various levels of severity, and a wide range of individual responses to the same treatments, the research on cancer progression has been challenging.

A turning point to the research has come with recent advances in nanotechnology, combined with engineering and medicine. Agah and his colleagues now have the critical ability to study the elastic or stretching ability of cells as well as their ability to stick to other cells. These studies on the biomechanics of the cell, linked to a cell's structure "are crucial for the development of disease-treating drugs and detection methods," Agah said.

Using an atomic force microscope (AFM), a relatively new invention by research standards, they are able to characterize cell structure to nanoscale precision. The microscope analyzes live cultured cells and it is able to detect key biomechanical differences between non-transformed and cancerous cells.

From these studies, cancerous cells appear softer or deform at a higher rate than their healthier, non-transformed counterparts, Agah said. In addition, their fluidity increases.

The Virginia Tech researchers selected to study ovarian cancer because it is one of the most lethal types in women and is normally diagnosed late in older patients when the disease has already progressed and metastasized.

Agah reported that no previous information existed about the biomechanical properties of both malignant and benign human ovarian cells, and how they change over time.

However, the mouse studies conducted by this interdisciplinary group of researchers at Virginia Tech have now shown how a cell, as it undergoes transformation towards malignancy, changes its size, loses its innate design of a tightly organized structure, and instead acquires the capacity to grow independently and form tumors.

"We have characterized the cells according to their phenotype into early-benign, intermediate, and late-aggressive stages of cancer that corresponded with their biomechanical properties," Agah reported.

"The mouse ovarian cancer model represents a valid and novel alternative to studying human cell lines and provides important information on the progressive stages of the ovarian cancer," Schmelz and Roberts commented.

"Cell viscosity is an important characteristic of a material because all materials exhibit some form of time-dependent strain," Agah said. This trait is an "imperative" part of any analysis of biological cells.

Their findings confirm that the cytoskeleton affects the biomechanical properties of cells. Changes in these properties can be related to the motility of cancer cells and potentially their ability to invade other cells.

"When cells undergo changes in their viscoelastic properties, they are increasingly able to deform, squeeze, and migrate through size-limiting pores of tissue or vasculature onto other parts of the body," Agah said.

Researchers at Yale School of Medicine have identified, characterized and cloned ovarian cancer stem cells and have shown that these stem cells may be the source of ovarian cancer’s recurrence and its resistance to chemotherapy.

(PhysOrg.com) -- Eliminating cancer stem cells (CSCs) within a tumor could hold the key to successful treatments for ovarian cancer, which has been notoriously difficult to detect and treat, according to new ...

(PhysOrg.com) -- Ovarian cancer is the most lethal reproductive cancer for women, with just one-fifth of women diagnosed with advanced disease surviving five years. It is frequently reported that less than one-third of ovarian ...

Cancer researchers have discovered that a type of regulatory RNA may be effective in fighting ovarian cancer. Ovarian cancer isn't typically discovered until it's in the advanced stages, where it is already ...

Recommended for you

Thanks to the work of an interdisciplinary team of researchers at the Dartmouth Center of Nanotechnology Excellence, funded by the National Institutes of Health, the next-generation magnetic nanoparticles ...

Here's the rub with friction—scientists don't really know how it works. Sure, humans have been harnessing the power of friction since rubbing two sticks together to build the first fire, but the physics of friction remains ...

Physicists at the University of Basel have shown for the first time that electrons in graphene can be moved along a predefined path. This movement occurs entirely without loss and could provide a basis for ...

Solar cells made out of lead sulfide quantum dots could eventually offer a cheaper, more flexible alternative to ones made using silicon, but they are currently much less efficient. However, altering the ...

Chemotherapy often shrinks tumors at first, but as cancer cells become resistant to drug treatment, tumors can grow back. A new nanodevice developed by MIT researchers can help overcome that by first blocking ...

Lithium-sulfur batteries have been a hot topic in battery research because of their ability to produce up to 10 times more energy than conventional batteries, which means they hold great promise for applications ...

User comments : 0

Please sign in to add a comment.
Registration is free, and takes less than a minute.
Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.

Javascript is currently disabled in your web browser. For full site functionality, it is necessary to enable Javascript.
In order to enable it, please see these instructions.